HOME >> BIOLOGY >> NEWS
Blood vessels found to signal chain of destruction in bone diseases

Biologists at Washington University in St. Louis have discovered a mechanism in blood vessels that opens the door for bone loss in such diseases as rheumatoid arthritis, periodontal disease, osteoporosis, tumor-associated bone loss, or artificial implant loosening.

Patricia Collin-Osdoby, Ph.D., research associate professor of biology in Arts & Sciences at Washington University, and Philip Osdoby, Ph.D., professor of biology in Arts & Sciences, and Linda Rothe, Washington University research associate, have for the first time shown that blood vessels at inflamed sites where bone loss is occurring create signals that set into motion a cascade of events leading to local bone destruction.

When an area of tissue in or near bone becomes inflamed, key molecules called cytokines are locally produced and increase in the bloodstream. Studying human tissue and cell samples, the Osdobys have shown that two key inflammatory cytokines, interleukin-1 (IL-1) and tumor necrosis factor (TNF), signal the endothelial cells of blood vessels and capillaries to make and display on their cell surface a molecule called RANKL. RANKL is the critical signal that tells the body to make and activate bone-degrading cells called osteoclasts. After osteoclasts take bone away, osteoblasts go back in and add new bone. Normally, this bone remodeling, which is associated with a blood vessel or capillary at such sites, is a carefully balanced process. However, in persons with inflammatory bone disease, osteoclasts out-number and out-work the bone-forming osteoblasts, leading to weakened bone matrix, bone loss, and an increased risk of fracture. The Osdobys believe that inflamed blood vessels beckon cells to the region, and then initiate their development into highly active bone-degrading osteoclasts.

The researchers also found that in this biochemical chain of events, the blood vessels themselves make an antagonist molecule, osteoprotegerin (OPG), whic
'"/>

Contact: Tony Fitzpatrick
tony_fitzpatrick@aismail.wustl.edu
314-935-5272
Washington University in St. Louis
26-Jun-2001


Page: 1 2 3 4

Related biology news :

1. Blood pressure hormone may inhibit growth of lung cancer
2. Blood tests identify patients on dialysis at high risk for death from cardiovascular disease
3. Blood banking systems improving in China, more progress needed
4. Blood proteins tied to inflammation
5. Bloodworms way with copper likely provides paradigm for new materials
6. Blood markers may reflect newborns potential of contracting HIV
7. Blood stem cells carry targeted genes
8. Blood vessels trigger development of the pancreas
9. Blood markers associated with autism and mental retardation
10. Blood test for diagnosing schizophrenia
11. Blood pressure-lowering DASH diet also reduces homocysteine

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/18/2020)... (PRWEB) , ... July 16, 2020 , ... ... that demonstrates the effectiveness of the Invictus Medical Neoasis™ active noise control device ... The study reported that the Neoasis™ device attenuated the alarm sounds from patient ...
(Date:7/4/2020)... ... July 03, 2020 , ... Aesthetics Biomedical (ABM), ... multiple awards for not only the products and treatments developed, but also the ... Microneedle RF. All the brands built by ABM have received several honors already ...
(Date:7/1/2020)... ... July 01, 2020 , ... Cure Glioblastoma, a registered 501(c)(3) ... and aggressive adult brain cancer—announced today the appointments of its first Senior Fellows: ... supporting the organization’s initiatives and overall vision. , "Senior Fellows are more than ...
Breaking Biology News(10 mins):
(Date:7/22/2020)... ... July 22, 2020 , ... Join experts from Reed Tech , Gary ... in a one hour live webinar on Thursday, August 13, 2020 at ... drugs and medical devices. Specifically, for medical devices, the NMPA has departments dealing with ...
(Date:7/18/2020)... ... ... “We are thrilled to deliver this new technology to the industry” said ... on the market and we were pleased that the IFT jury recognized that.” reFRESH™ ... creating a natural way to extend the shelf life and improve the safety of ...
(Date:7/18/2020)... TORONTO (PRWEB) , ... July 17, 2020 , ... ... and global consulting firm for the life sciences and food industries, is pleased ... new Director of Clinical Research – Business Development. , Charles is an accomplished ...
(Date:7/10/2020)... ... July 09, 2020 , ... PathSensors ... (MIT) has expanded the company’s exclusive license to include clinical applications for ... diagnostic market, focusing initially on the SARS-CoV-2 biosensor. CANARY’s™ fast and ...
Breaking Biology Technology:
Cached News: